Plasminogen activator inhibitor type 1 in platelets induces thrombogenicity by increasing thrombolysis resistance under shear stress in an in-vitro flow chamber model
No. | 25 |
---|---|
Citation | Thromb Res 146,p69-75(2016) |
Institute | Fujimori Kogyo |
1st Author | K Hosokawa |
AR | ○ |
PL | |
HD | |
Paper types | Basic science |
Main purpose | Drug efficacy evaluation |
Disease | |
Antiplatelet drug | |
Anticoagulant drug | |
Other drug | PAI-1, t-PA, u-PA |
Clinical specimens | |
Animal | PAI-1 deficient mouse |
Keyword |